Updated consensus statement on biological agents, specifically tumour necrosis factor α (TNFα) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2004

被引：55

作者：

Furst, DE

Breedveld, FC

Kalden, JR

Smolen, JS

Burmester, GR

Bijlsma, JWJ

Dougados, M

Emery, P

Keystone, EC

Klareskog, L

Mease, PJ

机构：

[1] Univ Calif Los Angeles, Div Rheumatol, Los Angeles, CA USA

[2] Leiden Univ, Med Ctr, Dept Rheumatol, Leiden, Netherlands

[3] Univ Erlangen Nurnberg, Inst Clin Immunol, Dept Internal Med 3, Erlangen, Germany

[4] Vienna Gen Hosp, Clin Internal Med 3, Inst Rheumatol, Vienna, Austria

[5] Charite Hosp, Dept Rheumatol & Clin Immunol, Berlin, Germany

[6] Univ Utrecht, Med Ctr, Dept Rheumatol & Clin Immunol, Utrecht, Netherlands

[7] Hop Cochin, Inst Rhumatol, Paris, France

[8] Univ Leeds, Gen Infirm, Dept Rheumatol, Leeds LS1 3EX, W Yorkshire, England

[9] Mt Sinai Hosp, Dept Rheumatol, Toronto, ON, Canada

[10] Karolinska Hosp, Dept Med, Rheumatol Unit, S-10401 Stockholm, Sweden

[11] Swedish Med Ctr, Med Ctr, Seattle, WA USA

来源：

关键词：

D O I：

10.1136/ard.2004.029272

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2 / 12

页数：11

共 169 条

[81] Etanercept - A review of its use in rheumatoid arthritis
Jarvis, B
Faulds, D
[J]. DRUGS, 1999, 57 (06) : 945 - 966
[82] Jones RE, 1999, B RHEUM DIS, V48, P1
[83] Infliximab in the treatment of refractory posterior uveitis
Joseph, A
Raj, D
Dua, HS
Powell, PT
Lanyon, PC
Powell, RJ
[J]. OPHTHALMOLOGY, 2003, 110 (07) : 1449 - 1453
[84] Kavanaugh A, 2004, J RHEUMATOL, V31, P849
[85] Anti-tumor necrosis factor-α monoclonal antibody therapy for rheumatoid arthritis
Kavanaugh, AF
[J]. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 1998, 24 (03) : 593 - +
[86] Tuberculosis associated with infliximab, a tumor necrosis factor (alpha)-neutralizing agent
Keane, J
Gershon, S
Wise, RP
Mirabile-Levens, E
Kasznica, J
Schwieterman, WD
Siegel, JN
Braun, MM
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (15) : 1098 - 1104
[87] Keystone E, 2002, ARTHRITIS RHEUM-US, V46, pS205
[88] Safety of tumour necrosis factor-α antagonists
Khanna, D
McMahon, M
Furst, DE
[J]. DRUG SAFETY, 2004, 27 (05) : 307 - 324
[89] Khanna D, 2003, J RHEUMATOL, V30, P1864
[90] KHANNA D, 2004, IN PRESS J RHEUMATOL